Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas
Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas, Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains July 22, 2025 SALT LA
BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)
BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV) July 8, 2025 Read the Medium Article from our CEO, Jared Bauer
Seek Labs Maps Measles Virus with BioSeeker™, Opening the Door to First-Ever Programmable Antiviral Therapeutic Amid Global Outbreaks
Seek Labs Maps Measles Virus with BioSeeker™, Opening the Door to First-Ever Programmable Antiviral Therapeutic Amid Global Outbreaks June 23, 2025 Read the Medium Article from o
Seek Labs Unveils BioSeeker™
Seek Labs Unveils BioSeeker™ Bioseeker™ is the AI Discovery Engine Powering Seek Labs’ Mission to Outpace Disease with Faster, Smarter Global Health Solutions June 10, 2025 R
Seek Labs Joins Global African Swine Fever Research Alliance (GARA)
Seek Labs Joins Global African Swine Fever Research Alliance (GARA) September 16, 2024 Seek Labs is excited to announce its participation in the Global African Swine Fever Research
Doug Gladue, VP of Veterinary Pharmaceutical Development, Presents at PROCINORTE Priority Animal Diseases 2024 Workshop
Doug Gladue, VP of Veterinary Pharmaceutical Development, Presents at PROCINORTE Priority Animal Diseases 2024 Workshop June 12, 2024 Today, Dr. Douglas Gladue, VP of Veterinary Ph
Seek Labs Appoints Renowned African Swine Fever Researcher, Douglas Gladue, PhD, as Vice President of Veterinary Pharmaceutical Development
Renowned African Swine Fever Researcher, Douglas Gladue, PhD, joins Seek Labs as Vice President of Veterinary Pharmaceutical Development June 3, 2024 SALT LAKE CITY, UTAH, June 3,
Alison O’Mahony Named One of 30 Women to Watch 2024 by Utah Business
Dr. Alison O’Mahony, Vice President of Pharmaceutical Research, Named One of 30 Women to Watch 2024 by Utah Business May 30, 2024 This week, Alison O’Mahony, VP of Phar
Seek Labs Announces Successful Completion of African Swine Fever Virus In Vivo Trial Utilizing CRISPR-based Treatments
Seek Labs Announces Successful Completion of African Swine Fever Virus In Vivo Trial Utilizing CRISPR-based Treatments May 6, 2024 SALT LAKE CITY, UT (Business Wire) – Seek L
Seek Labs Welcomes Alison O’Mahony, PhD as new Vice President of Pharmaceutical Research
Seek Labs Welcomes Alison O’Mahony, PhD as new Vice President of Pharmaceutical Research February 22, 2024 SALT LAKE CITY, UT, February 22, 2024 (BusinessWire) – Seek Labs,